CARA – cara therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024
Oruka Therapeutics Expands Leadership Team, Naming Joana Goncalves, MBChB, as Chief Medical Officer [Yahoo! Finance]
Uremic Pruritus Pipeline Insight 2024, Featuring Key Players Cara Therapuetics and Lumosa Therapeutics, and Key Emerging Drugs Cara Therapeutics CR845 and Lumos Therapeutics' LT 5001 [Yahoo! Finance]
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Form 4 Cara Therapeutics, Inc. For: May 02 Filed by: Posner Christopher
Form DEFA14A Cara Therapeutics, Inc.
Form ARS Cara Therapeutics, Inc. For: Dec 31
Form DEF 14A Cara Therapeutics, Inc. For: Jun 04
Form PRE 14A Cara Therapeutics, Inc. For: Jun 04
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.